Industry3h ago
Anthropic Launches AI Drug Discovery Program
Anthropic is starting its own drug development program to target neglected diseases ignored by Big Pharma. This move leverages AI to tackle conditions deemed unprofitable by traditional firms. Novartis estimates AI can shrink development timelines from twelve years to eight. Such efficiency gains could double clinical success rates for practitioners in the biotech sector.